Earnings Call · Q3 FY2025·2025-10-21

Q3 25EPS +22.06%·Rev n/aQ2 25EPS -0.90%·Rev n/aQ1 25EPS +4.27%·Rev n/aQ4 24EPS -0.26%·Rev n/a⚠ consensus missing

Elevance Health, Inc. ELV

Nathan Rich — Vice President, Investor Relations

Gail Boudreaux — President and Chief Executive Officer

Mark Kaye — Chief Financial Officer

−1.2%1d on move date−1.2% vs SPY3d−2.2%5d−3.3%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ELV calls or request research access.

More ELV calls Browse calls Request research access